Apixaban for Stroke Prevention in Patients With Subclinical Atrial Fibrillation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation
N. Engl. J. Med 2023 Nov 12;[EPub Ahead of Print], JS Healey, RD Lopes, CB Granger, M Alings, L Rivard, WF McIntyre, D Atar, DH Birnie, G Boriani, AJ Camm, D Conen, JW Erath, MR Gold, SH Hohnloser, J Ip, J Kautzner, V Kutyifa, C Linde, P Mabo, G Mairesse, J Benezet Mazuecos, J Cosedis Nielsen, F Philippon, M Proietti, C Sticherling, JA Wong, DJ Wright, IG Zarraga, SB Coutts, A Kaplan, M Pombo, F Ayala-Paredes, L Xu, K Simek, S Nevills, R Mian, SJ ConnollyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.